DiObex diobex.com


DiObex is a biopharmaceutical company that has one of the lead compounds for the treatment of type 2 diabetes via the innovative cortisol pathway in clinical testing. This new mechanism of action might also lead to the prevention of metabolic syndrome. Their pipeline includes products targeted at medical needs in metabolic disorders including type 1 diabetes, dyslipidemia, obesity, and diabetic nephropathy.

DiObex is a biopharmaceutical company that has one of the lead compounds for the treatment of type 2 diabetes via the innovative cortisol pathway in clinical testing. This new mechanism of action might also lead to the prevention of metabolic syndrom...Show all

Company (Dead / Inactive)

Phone: 415-551-0400

Fax:

600 Townsend Street
Suite 271
San Francisco, 94103
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
DiObex $31.1M Apr 9, 2009
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related DiObex Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 6 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors
See all 16 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Methods relating to hypoglycemic unawareness Oct 29, 2007 Mar 23, 2010 Patent
Methods for reducing the risk of hypoglycemia Oct 29, 2007 Mar 16, 2010 Patent
Compositions and methods for the prevention and control of insulin-induced hypoglycemia Oct 29, 2007 Mar 16, 2010 Patent
Compositions and methods for the prevention and control of insulin-induced hypoglycemia Jun 28, 2005 Feb 02, 2010 Patent